EUVIMEDOpdag EUVIMED
Crossref

Global Burden of Female Breast Cancer Attributable to High Fasting Plasma Glucose From 1990 to 2021 and Projections to 2046: An Analysis for the Global Burden of Disease Study 2021

Donglin Jiang, Siyao Ma, Yangxue Wu, Jicun Zhu, Qian Yang, Ling Liu, Tiandong Li, Yin Lu, Yuqi Liu, Peng Wang, Keyan Wang, Jianxiang Shi and 1 more

Diabetes/Metabolism Research and Reviews · 2025-07 · 41 (5)

DOI: 10.1002/dmrr.70063 ↗

At a glance

Journal article in Diabetes/Metabolism Research and Reviews, published online on 2025-07-01. Written by Donglin Jiang and 12 co-authors. Institution: College of Public Health, Zhengzhou University, Zhengzhou, China. Major MEDLINE topics: Breast Neoplasms, Blood Glucose, Global Burden of Disease, Fasting. Cited 2 times so far (Crossref); 48 references. Funded by: Key Research Program of Higher Education in Henan Province, Funds for Research and Development of Key Technologies for a Personalized Assessment of Nutritional Genetic Risk Based on Central Plains Population and Evaluat….

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

High fasting plasma glucose (HFPG) plays an important role in the progression of breast cancer. This study aims to assess the global time trends of female breast cancer attributable to HFPG from 1990 to 2021 and projections to 2046.

Methods

This study obtained the number and age‐standardised rate of deaths and disability‐adjusted life years (DALYs) of female breast cancer burden attributable to HFPG by age, region, country, and socio‐demographic index (SDI) from 1990 to 2021. Average Annual Percentage Change (AAPC) was analysed to assess time trends in female breast cancer burden attributable to HFPG. The age‐period‐cohort model was used to project the global burden by 2046.

Results

In 2021, 4.62% of female breast cancer deaths (30,000) and 4.04% of DALYs (820,000) globally were attributed to HFPG. Compared with 1990, the age‐standardised mortality rate (ASMR) and age‐standardised DALY rate (ASDR) increased, with AAPCs of 0.76 (95% CI: 0.71, 0.89) and 0.86 (95% CI: 0.84, 0.98), respectively. The burden of breast cancer attributable to HFPG was higher in the elderly and low SDI regions. Additionally, the burden of female breast cancer attributable to HFPG is projected to continue to increase through 2046.

Conclusions

The burden of female breast cancer attributable to HFPG has increased over the past three decades and will continue to increase over the next 25 years. Therefore, it is important to control blood sugar to reduce the burden of breast cancer.

Subjects

MeSH terms (MEDLINE)

Breast NeoplasmsBlood GlucoseGlobal Burden of DiseaseFastingHumansFemaleMiddle AgedAdultAgedGlobal HealthDisability-Adjusted Life YearsPrognosisFollow-Up Studies

Author keywords

breast cancerhigh fasting plasma glucoseprojectiontrends

Substances

Blood Glucose

Authors and institutions

  • College of Public Health, Zhengzhou University, Zhengzhou, China.
  • Henan Key Laboratory of Tumor Epidemiology, Zhengzhou, China.
  • Henan International Joint Laboratory of Tumor Biomarkers and Molecular Imaging, Zhengzhou, China.
  • National Key Laboratory of Metabolism Disorder and Esophageal Cancer Prevention and Treatment, Zhengzhou, China.
  • Minhang Crosspoint High School, Shanghai, China.
  • Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

ORCID profiles: Hua Ye

Funding

  • Key Research Program of Higher Education in Henan Province
  • Funds for Research and Development of Key Technologies for a Personalized Assessment of Nutritional Genetic Risk Based on Central Plains Population and Evaluat…

Cite

APA

Jiang, D., Ma, S., Wu, Y., Zhu, J., Yang, Q., Liu, L., Li, T., Lu, Y., Liu, Y., Wang, P., Wang, K., Shi, J., & Ye, H. (2025). Global Burden of Female Breast Cancer Attributable to High Fasting Plasma Glucose From 1990 to 2021 and Projections to 2046: An Analysis for the Global Burden of Disease Study 2021. Diabetes/Metabolism Research and Reviews, 41(5). https://doi.org/10.1002/dmrr.70063

Vancouver

Jiang D, Ma S, Wu Y, Zhu J, Yang Q, Liu L, et al. Global Burden of Female Breast Cancer Attributable to High Fasting Plasma Glucose From 1990 to 2021 and Projections to 2046: An Analysis for the Global Burden of Disease Study 2021. Diabetes/Metabolism Research and Reviews. 2025;41(5). doi:10.1002/dmrr.70063

BibTeX
@article{Jiang2025,
  author = {Jiang, Donglin and Ma, Siyao and Wu, Yangxue and Zhu, Jicun and Yang, Qian and Liu, Ling and Li, Tiandong and Lu, Yin and Liu, Yuqi and Wang, Peng and Wang, Keyan and Shi, Jianxiang and Ye, Hua},
  title = {Global Burden of Female Breast Cancer Attributable to High Fasting Plasma Glucose From 1990 to 2021 and Projections to 2046: An Analysis for the Global Burden of Disease Study 2021},
  journal = {Diabetes/Metabolism Research and Reviews},
  year = {2025},
  volume = {41},
  number = {5},
  doi = {10.1002/dmrr.70063}
}
Start for free →